Stocks TelegraphStocks Telegraph
Stock Ideas

EPRX Stock Performance and Key Statistics

NASDAQ : EPRX

Eupraxia Pharmaceuticals

$6.16
-0.36-5.52%
At Close 4:00 PM

stock performance chart

EPRX Fundamental Analysis

Based on recent data, Eupraxia Pharmaceuticals Inc. (EPRX) shows an Average True Range (ATR) of 0.46 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 293.91K, indicating liquidity. These fundamental metrics provide insight into EPRX's underlying financial health and market activity.

ATR0.46
Enterprise Value-
Avg Vol (3 Months)293.91K
Avg Vol (10 Days)183.79K

EPRX Technical Analysis Indicators

Eupraxia Pharmaceuticals Inc. (EPRX) technical indicators as of July 17, 2026: the SMA 20 is -1.9%, SMA 50 at 1.85%, and SMA 200 at 36.33%. The RSI 14 value is 48.91, suggesting its current momentum. These technical analysis signals help assess EPRX's price trends and potential future movements.

SMA 20-1.9%
SMA 501.85%
SMA 20036.33%
RSI 1448.91

EPRX Stock Performance Overview

Eupraxia Pharmaceuticals Inc. (EPRX) stock performance overview as of July 17, 2026: The 52-week high is $9.32 (currently -12.23% below), and the 52-week low is $4.88 (currently 205.21% above). Over the past year, EPRX's performance is 199.67%, compared to the S&P 500's 5.44% change.

52-Week High9.32
52-Week High Chg-12.23%
52-Week Low4.88
52-Week Low Chg+205.21%
S&P 500 52-Week Chg5.44%

Eupraxia Pharmaceuticals Inc. (EPRX) Historical Stock Performance

According to market data, Eupraxia Pharmaceuticals Inc. (EPRX) stock's recent performance metrics show that over the last month, EPRX is 43.4%, with a Year-to-Date (YTD) performance of 19.47%. Over the past year, the stock has seen a 199.67% change. These figures summarize EPRX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High7.037.118.029.329.329.32
Low6.085.635.635.634.885.63
Performance+10.00%+43.40%+56.06%+73.80%+199.67%+19.47%

Industry Analysis and Valuation

According to current financial data, EPRX stock's P/E (TTM) ratio is -6.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for EPRX, including P/S (N/A), P/B (2.52), and P/FCF (-6.37), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationEPRXSector MedianIndustry AvgS&P 500
P/E (TTM)-6.12-1.22-194.0232.59
P/S (TTM)N/A3.69466.985.98
P/B (TTM)2.52010.725.35
P/FCF (TTM)-6.37-6.3-601.1430.26

Frequently Asked Questions

How is EPRX price-to-earnings ratio currently?
EPRX has a current P/E ratio of -6.12
How are EPRX's price-to-sale and price-to-book ratios?
The EPRX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 2.52.
Is Eupraxia Pharmaceuticals Inc.'s price-to-cashflow ratio high or low?
EPRX's price-to-free-cashflow (P/FCF) ratio is -6.37, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for EPRX?
Based on EPRX's recent bid, its distance from 20 days simple moving average is -1.9%. It is 1.85% apart from 50 days simple moving average, and it is 36.33% apart from 200 days simple moving average.
What is the 52-week price range for EPRX?
The 52-week high for EPRX is $9.32 which is -12.23% away from the current price level whereas the distance of that from the 52-week low of $4.88 stands at 205.21%.
An overview of EPRX's stock performance: how did it fare?
The performance of EPRX stock was not encouraging with most of its significant price indicators in green. Eupraxia Pharmaceuticals Inc.(NASDAQ: EPRX) shares have moved downward -5.52% or - $0.36 in the latest trading session and have gained 19.47% year-to-date (YTD). The stock has gained nearly 199.67% over the past year. After moving 56.06% over the trailing 3-month period, the stock is 73.8% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 10% a week and 43.4% a month.
What is EPRX's 14-day relative strength index (RSI)?
The current 14-day RSI for EPRX stock is 48.91. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For EPRX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Eupraxia Pharmaceuticals Inc. (EPRX) has a 14-day ATR of 0.46.
What is EPRX's current enterprise value?
After closing at $6.52 with 33.48M of its shares outstanding, the current enterprise value of EPRX is roughly -.
Over the past year, how has the stock price of EPRX changed?
Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX) is up 199.67% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 5.44%. EPRX stock price is also up 19.47% on its value in year-to-date trading.
What is the average trading volume for EPRX shares?
The number outstanding shares of EPRX is 33.48M, and of these 69.54% shares are freely available for trading. On average, EPRX stock has traded 183.79K shares per day for the past 10 days. A total of 165.88K shares changed hands during the last trading session with the average session volume of 295.68K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph